Fifth Circuit Partially Upholds Stay Order in Medication Abortion Litigation | Practical Law
In litigation involving the Food and Drug Administration's (FDA's) approval process for mifepristone (a widely used medication abortion drug), the Fifth Circuit vacated a portion of a lower court order staying the FDA's initial approval of mifepristone. However, the Fifth Circuit affirmed the portion of the lower court's order that stayed the FDA's administrative actions from 2016 (and more recent years) that generally relaxed certain safeguards involving the use of mifepristone.